Gilbert M. Rishton

Corporate Officer/Principal at CARDAX, INC.

Health Technology

Consumer Services

Gilbert M. Rishton active positions

Companies	Position	Start	End
CARDAX, INC.	Corporate Officer/Principal	-	-
CARDAX, INC.	Chief Tech/Sci/R&D Officer	31/12/2007	-

Companies	Position	Start	End
Channel Islands Alzheimer's Institute	Director/Board Member	31/10/2004	30/11/2010
Channel Islands Alzheimer's Institute	Founder	31/10/2004	30/11/2010
AMGEN INC.	Corporate Officer/Principal	31/12/1994	-
COGNITION THERAPEUTICS, INC.	Founder	20/08/2007	-
COGNITION THERAPEUTICS, INC.	Corporate Officer/Principal	10/08/2009	-
Cardax Pharmaceuticals, Inc. Cardax Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Cardax Pharmaceuticals, Inc. develops proprietary small molecule therapies for large unmet medical needs. It develops proprietary small molecule therapies for large unmet needs where oxidative stress and inflammation play important causative roles-including cardiovascular disease, hepatitis, macular degeneration and many cancers. The company's proprietary, synthetic, natural compound derivatives represent a novel treatment approach that offers efficacy along with an outstanding safety profile, oral bioavailability and tissue selectivity. Cardax Pharmaceuticals was founded by David G. Watumull and Samuelf Lockwood in May 2006 and is headquartered in Honolulu, HI.	Chief Tech/Sci/R&D Officer	01/07/2009	-

Florida State University	Doctorate Degree
University of Rhode Island	Undergraduate Degree

International

United States

Operational

Corporate Officer/Principal	3
Chief Tech/Sci/R&D Officer	2
Founder	2

Sectoral

Health Technology	5
Consumer Services	3

Positions held

Active

Inactive

Listed companies

Private companies

Private companies	2
Cardax Pharmaceuticals, Inc. Cardax Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Cardax Pharmaceuticals, Inc. develops proprietary small molecule therapies for large unmet medical needs. It develops proprietary small molecule therapies for large unmet needs where oxidative stress and inflammation play important causative roles-including cardiovascular disease, hepatitis, macular degeneration and many cancers. The company's proprietary, synthetic, natural compound derivatives represent a novel treatment approach that offers efficacy along with an outstanding safety profile, oral bioavailability and tissue selectivity. Cardax Pharmaceuticals was founded by David G. Watumull and Samuelf Lockwood in May 2006 and is headquartered in Honolulu, HI.	Health Technology
Channel Islands Alzheimer's Institute

Private companies

Health Technology

Channel Islands Alzheimer's Institute